Search for: "State v. Dupre" Results 1 - 19 of 19
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2015, 10:54 am by Brian Frye
The most important Supreme Court decision of 2015 was probably Obergefell v. [read post]
13 Feb 2009, 12:01 am
E-mails from investors demanding information about defendant's fraudulent scheme were not hearsay when offered to provide context for the defendant's message, to rebut the defendant's argument that she did not know the scheme was fraudulent, and to show the defendant had received communications indicating the fraudulent nature of the project, in United States v. [read post]
16 Nov 2008, 8:51 pm
(on the application of Al-Jedda) v Secretary of State for Defence: Human Rights and Accountability in International Military OperationsCatherine Dupré, After Reforms: Human Rights Protection in Post-Communist StatesDavid G. [read post]
17 Sep 2015, 8:02 am
Catherine est par conte la femme de Dupré eten même temps la maîtressede Maître Cassidi,à qui elle avoue d'être l'auteur du crime. [read post]
28 Mar 2008, 6:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Forbes interview with M Meurer (co author of ‘Patent Failure’): (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (IAM), (Technological Innovation and Intellectual Property), (Patent Prospector),Rambus – Rambus stock soars following jury’s dismissal of antitrust and fraud charges from Hynix, Micron, and Nanya that… [read post]
21 Mar 2008, 5:01 pm
He’s claiming that photos of Alexandra Dupre found in the media are violating copyright laws. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]